| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.4M | -27.5% |
| R&D Expense | $221.0M | +66.3% |
| SG&A Expense | $51.6M | -1.4% |
| Operating Income | -$243.4M | -66.9% |
| Pre-tax Income | -$231.7M | -77.2% |
| Income Tax | $279K | +210.0% |
| Net Income | -$232.0M | -77.2% |
| EPS (Basic) | -$3.17 | -36.6% |
| EPS (Diluted) | -$3.17 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.8M | +2.1% |
| Short-term Investments | $204.3M | -24.7% |
| Accounts Receivable | $651K | +7.2% |
| Inventory | $1.8M | -21.3% |
| Current Assets | $328.7M | -14.3% |
| Total Assets | $364.0M | -13.0% |
| Current Liabilities | $37.0M | -24.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$240.1M | -90.2% |
| Capital Expenditures | $3.3M | -19.1% |
| Investing Cash Flow | $68.6M | +131.3% |
| Financing Cash Flow | $173.6M | +5.9% |
| Free Cash Flow | -$243.4M | -86.8% |
| -36.6% |
| Total Liabilities |
| $57.9M |
| -29.4% |
| Stockholders' Equity | $306.1M | -9.0% |